Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Other Stocks, New, 2023 Q4, Page 2

CITADEL ADVISORS LLC historic quarter change: USA Other Stocks, New

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 8,173 positions, added to 6,540, reduced 6,603 and sold out of 7,821.

  • Q4 2023: Stock SOTHERLY HOTELS INC; Country of operation —; Class COM; Shares before 0.
  • Q4 2023: Stock GALECTO INC; Country of operation —; Class COM; Shares before 0.
  • Q4 2023: Stock SONNET BIOTHERAPEUTC HLDNG I; Country of operation —; Class COM; Shares before 0.
  • Q4 2023: Stock SUNSHINE BIOPHARMA INC; Country of operation —; Class COM NEW; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2023SOTHERLY HOTELS INC
CUSIP 83600C103
—COM035,362+35,362$0$52,689+$52,6892024-02-14
Q4 2023GALECTO INC
CUSIP 36322Q107
—COM072,433+72,433$0$52,151+$52,1512024-02-14
Q4 2023SONNET BIOTHERAPEUTC HLDNG I
CUSIP 83548R303
—COM029,447+29,447$0$51,238+$51,2382024-02-14
Q4 2023SUNSHINE BIOPHARMA INC
CUSIP 867781403
—COM NEW0185,255+185,255$0$50,297+$50,2972024-02-14
Q4 2023DZS INC
CUSIP 268211109
—COM025,359+25,359$0$49,957+$49,9572024-02-14
Q4 2023KIORA PHARMACEUTICALS INC
CUSIP 49721T309
—COM NEW092,585+92,585$0$49,070+$49,0702024-02-14
Q4 2023SYROS PHARMACEUTICALS INC
CUSIP 87184Q206
—COM NEW06,180+6,180$0$48,142+$48,1422024-02-14
Q4 2023TREVENA INC
CUSIP 89532E208
—COM NEW067,565+67,565$0$47,674+$47,6742024-02-14
Q4 2023APTEVO THERAPEUTICS INC
CUSIP 03835L207
—COM NEW0262,124+262,124$0$47,444+$47,4442024-02-14
Q4 2023AKERNA CORP
CUSIP 00973W300
—COM NEW0108,102+108,102$0$47,024+$47,0242024-02-14
Q4 2023THERATECHNOLOGIES INC
CUSIP 88338H704
—COM NEW028,691+28,691$0$46,479+$46,4792024-02-14
Q4 2023TRANSCODE THERAPEUTICS INC
CUSIP 89357L204
—COM NEW0281,908+281,908$0$46,458+$46,4582024-02-14
Q4 2023S&W SEED CO
CUSIP 785135104
—COM065,946+65,946$0$46,162+$46,1622024-02-14
Q4 2023ADVENT TECHNOLOGIES HOLDNG I
CUSIP 00788A105
—COM CL A0206,257+206,257$0$45,954+$45,9542024-02-14
Q4 2023STAR EQUITY HOLDINGS INC
CUSIP 85513Q103
—COM044,712+44,712$0$45,606+$45,6062024-02-14
Q4 2023MINK THERAPEUTICS INC
CUSIP 603693102
—COM042,141+42,141$0$45,301+$45,3012024-02-14
Q4 2023ROCKWELL MED INC
CUSIP 774374300
United StatesCOM NEW023,841+23,841$0$45,059+$45,0592024-02-14
Q4 2023LONGEVERON INC
CUSIP 54303L104
—COM032,253+32,253$0$43,864+$43,8642024-02-14
Q4 2023HALL OF FAME RESORT & ENTMT
CUSIP 40619L201
—COM NEW013,354+13,354$0$43,401+$43,4012024-02-14
Q4 2023COLLPLANT BIOTECHNOLOGIES LT
CUSIP M2R51X116
—SHS NEW06,734+6,734$0$43,030+$43,0302024-02-14
Q4 2023T STAMP INC
CUSIP 873048409
—CL A NEW031,356+31,356$0$42,958+$42,9582024-02-14
Q4 2023VBI VACCINES INC CDA
CUSIP 91822J202
—COM NEW072,449+72,449$0$42,564+$42,5642024-02-14
Q4 2023LULUS FASHION LOUNGE HOLDING
CUSIP 55003A108
—COM022,677+22,677$0$42,179+$42,1792024-02-14
Q4 2023SYNLOGIC INC
CUSIP 87166L209
—COM NEW010,860+10,860$0$41,811+$41,8112024-02-14
Q4 2023MODULAR MED INC
CUSIP 60785L207
—COM NEW022,797+22,797$0$41,491+$41,4912024-02-14
Q4 2023EXELA TECHNOLOGIES INC
CUSIP 30162V805
—COM012,227+12,227$0$41,083+$41,0832024-02-14
Q4 2023SCIENJOY HOLDING CORP
CUSIP G7864D112
—CLASS A ORD011,508+11,508$0$40,048+$40,0482024-02-14
Q4 2023COMPUGEN LTD
CUSIP M25722105
—ORD019,943+19,943$0$39,487+$39,4872024-02-14
Q4 2023URBAN-GRO INC
CUSIP 91704K202
—COM NEW028,052+28,052$0$39,273+$39,2732024-02-14
Q4 2023PROFIRE ENERGY INC
CUSIP 74316X101
—COM021,642+21,642$0$39,172+$39,1722024-02-14
Q4 2023MAINZ BIOMED N V
CUSIP N5436L101
—ORDINARY SHARES033,244+33,244$0$38,563+$38,5632024-02-14
Q4 2023CAMBER ENERGY INC
CUSIP 13200M607
—COM0166,640+166,640$0$38,061+$38,0612024-02-14
Q4 2023OLB GROUP INC
CUSIP 67086U307
—COM035,050+35,050$0$37,153+$37,1532024-02-14
Q4 2023LEXARIA BIOSCIENCE CORP
CUSIP 52886N406
United StatesCOM NEW029,561+29,561$0$36,951+$36,9512024-02-14
Q4 2023BIOSIG TECHNOLOGIES INC
CUSIP 09073N201
—COM NEW077,254+77,254$0$36,696+$36,6962024-02-14
Q4 2023KINETA INC
CUSIP 49461C102
—COM010,015+10,015$0$35,553+$35,5532024-02-14
Q4 2023SRIVARU HOLDING LIMITED
CUSIP G8403L102
—ORD SHS099,793+99,793$0$35,446+$35,4462024-02-14
Q4 2023PHOENIX MTR INC
CUSIP 71910P203
—COM NEW033,983+33,983$0$35,342+$35,3422024-02-14
Q4 2023FISCALNOTE HOLDINGS INC
CUSIP 337655104
—COM CL A030,748+30,748$0$35,052+$35,0522024-02-14
Q4 2023VISION MARINE TECHNOLOGIES I
CUSIP C96657116
—COM031,533+31,533$0$34,371+$34,3712024-02-14
Q4 2023LAVA THERAPEUTICS NV
CUSIP N51517105
—SHS021,552+21,552$0$34,052+$34,0522024-02-14
Q4 2023OPTINOSE INC
CUSIP 68404V100
—COM025,623+25,623$0$33,054+$33,0542024-02-14
Q4 2023GRI BIO INC
CUSIP 3622AW106
—COM086,125+86,125$0$33,020+$33,0202024-02-14
Q4 2023LYTUS TECHNOLOGS HLDGS PTV L
CUSIP G5851A109
—COM0285,589+285,589$0$31,700+$31,7002024-02-14
Q4 2023UNICYCIVE THERAPEUTICS INC
CUSIP 90466Y103
—COM035,420+35,420$0$30,734+$30,7342024-02-14
Q4 2023PLUS THERAPEUTICS INC
CUSIP 72941H509
United StatesCOM016,839+16,839$0$30,142+$30,1422024-02-14
Q4 2023JAGUAR HEALTH INC
CUSIP 47010C706
—COM0193,330+193,330$0$29,270+$29,2702024-02-14
Q4 2023INDAPTUS THERAPEUTICS INC
CUSIP 45339J105
—COM016,518+16,518$0$29,237+$29,2372024-02-14
Q4 2023ONCTERNAL THERAPEUTICS INC
CUSIP 68236P107
—COM054,279+54,279$0$29,104+$29,1042024-02-14
Q4 2023FORIAN INC
CUSIP 34630N106
United StatesCOM09,909+9,909$0$28,984+$28,9842024-02-14
Q4 2023SENTI BIOSCIENCES INC
CUSIP 81726A100
—COM043,703+43,703$0$28,844+$28,8442024-02-14
Q4 2023VISIONARY ED TEC HLDGS GRP I
CUSIP 92838F101
—COM0136,866+136,866$0$28,742+$28,7422024-02-14
Q4 2023INPIXON
CUSIP 45790J867
—COM NEW 20220506,667+506,667$0$28,475+$28,4752024-02-14
Q4 2023XILIO THERAPEUTICS INC
CUSIP 98422T100
United StatesCOM051,419+51,419$0$28,280+$28,2802024-02-14
Q4 2023CYNGN INC
CUSIP 23257B107
—COM0194,809+194,809$0$28,189+$28,1892024-02-14
Q4 2023MILLENNIUM GROUP INTL HLDGS
CUSIP G6169A104
—ORD SHS022,202+22,202$0$27,530+$27,5302024-02-14
Q4 2023WINDTREE THERAPEUTICS INC
CUSIP 97382D402
—COM NEW038,128+38,128$0$27,414+$27,4142024-02-14
Q4 2023IN8BIO INC
CUSIP 45674E109
—COM019,807+19,807$0$27,334+$27,3342024-02-14
Q4 2023AMERICAN LITHIUM CORP
CUSIP 027259209
—COM NEW024,684+24,684$0$27,152+$27,1522024-02-14
Q4 2023OSTIN TECHNOLOGY GROUP CO LT
CUSIP G67927106
—ORDINARY SHARES034,659+34,659$0$27,072+$27,0722024-02-14
Q4 2023BM TECHNOLOGIES INC
CUSIP 05591L107
—CL A COM013,117+13,117$0$26,890+$26,8902024-02-14
Q4 2023EARGO INC
CUSIP 270087208
—COM NEW010,376+10,376$0$26,874+$26,8742024-02-14
Q4 2023BLUEJAY DIAGNOSTICS INC
CUSIP 095633301
—COM NEW022,077+22,077$0$26,824+$26,8242024-02-14
Q4 2023ZENVIA INC
CUSIP G9889V101
—CLASS A COM022,579+22,579$0$26,643+$26,6432024-02-14
Q4 2023PROKIDNEY CORP
CUSIP G7S53R104
—CLASS A ORD SHS014,616+14,616$0$26,016+$26,0162024-02-14
Q4 2023BIOTRICITY INC
CUSIP 09074H203
—COM NEW021,637+21,637$0$25,532+$25,5322024-02-14
Q4 2023PORTAGE BIOTECH INC
CUSIP G7185A128
—COM014,139+14,139$0$25,450+$25,4502024-02-14
Q4 2023ADVERUM BIOTECHNOLOGIES INC
CUSIP 00773U108
—COM033,713+33,713$0$25,379+$25,3792024-02-14
Q4 2023MSP RECOVERY INC
CUSIP 553745209
—CL A NEW011,031+11,031$0$25,040+$25,0402024-02-14
Q4 2023THERIVA BIOLOGICS INC
CUSIP 87164U409
—COM NEW057,953+57,953$0$24,926+$24,9262024-02-14
Q4 2023ANGHAMI INC
CUSIP G0369L101
—ORD SHS023,767+23,767$0$24,718+$24,7182024-02-14
Q4 2023LEDDARTECH HLDGS INC
CUSIP 52328E105
—COM09,586+9,586$0$24,588+$24,5882024-02-14
Q4 2023PHIO PHARMACEUTICALS CORP
CUSIP 71880W402
—COM031,843+31,843$0$24,201+$24,2012024-02-14
Q4 2023GSE SYS INC
CUSIP 36227K205
—COM NEW011,556+11,556$0$23,690+$23,6902024-02-14
Q4 2023YS BIOPHARMA CO LTD
CUSIP G9845F109
—ORDINARY SHARES042,855+42,855$0$23,056+$23,0562024-02-14
Q4 2023VIVAKOR INC
CUSIP 92852R403
—COM NEW022,347+22,347$0$22,570+$22,5702024-02-14
Q4 2023BIOCARDIA INC
CUSIP 09060U507
—COM033,629+33,629$0$22,336+$22,3362024-02-14
Q4 2023TOUGHBUILT INDS INC
CUSIP 89157G884
—COM0140,581+140,581$0$22,142+$22,1422024-02-14
Q4 2023ACELRX PHARMACEUTICALS INC
CUSIP 00444T209
United StatesCOM NEW029,898+29,898$0$21,975+$21,9752024-02-14
Q4 2023STRAN & COMPANY INC
CUSIP 86260J102
United StatesCOMMON STOCK014,823+14,823$0$21,938+$21,9382024-02-14
Q4 2023RENT THE RUNWAY INC
CUSIP 76010Y103
—COM CL A041,350+41,350$0$21,812+$21,8122024-02-14
Q4 2023SENESTECH INC
CUSIP 81720R505
—COM NEW017,150+17,150$0$21,781+$21,7812024-02-14
Q4 2023ACUTUS MED INC
CUSIP 005111109
—COM0107,673+107,673$0$21,739+$21,7392024-02-14
Q4 2023GROM SOCIAL ENTRPRISES INC
CUSIP 39878L506
—COM019,065+19,065$0$21,543+$21,5432024-02-14
Q4 2023NEPTUNE WELLNESS SOLUTIONS I
CUSIP 64079L303
—COM NEW039,064+39,064$0$21,532+$21,5322024-02-14
Q4 2023PAXMEDICA INC
CUSIP 70424C203
—COM NEW027,973+27,973$0$21,176+$21,1762024-02-14
Q4 2023SONOMA PHARMACEUTICALS INC
CUSIP 83558L204
—COM NEW0116,779+116,779$0$21,067+$21,0672024-02-14
Q4 2023GAUCHO GROUP HLDGS INC
CUSIP 36809R404
—COM NEW035,741+35,741$0$20,780+$20,7802024-02-14
Q4 20235E ADVANCED MATERIALS INC
CUSIP 33830Q109
—COMMON STOCK014,329+14,329$0$20,204+$20,2042024-02-14
Q4 2023CHINA PHARMA HLDGS INC
CUSIP 16941T203
—COM0166,213+166,213$0$20,112+$20,1122024-02-14
Q4 2023CASTELLUM INC
CUSIP 14838T204
—COM NEW066,865+66,865$0$19,926+$19,9262024-02-14
Q4 2023ENVIROTECH VEHICLES INC
CUSIP 29414V209
—COM NEW014,894+14,894$0$19,660+$19,6602024-02-14
Q4 2023ISPECIMEN INC
CUSIP 45032V108
—COM038,809+38,809$0$19,428+$19,4282024-02-14
Q4 2023ENERGOUS CORP
CUSIP 29272C202
—COM NEW010,560+10,560$0$19,325+$19,3252024-02-14
Q4 2023QUALIGEN THERAPEUTICS INC
CUSIP 74754R202
—COM NEW034,779+34,779$0$19,128+$19,1282024-02-14
Q4 2023GLYCOMIMETICS INC
CUSIP 38000Q102
—COM07,886+7,886$0$18,611+$18,6112024-02-14
Q4 2023AETERNA ZENTARIS INC
CUSIP 007975501
—COM NEW010,002+10,002$0$18,604+$18,6042024-02-14
Q4 2023SWVL HOLDINGS CORP
CUSIP G86302125
—CLASS A ORD NEW010,915+10,915$0$18,228+$18,2282024-02-14
Q4 2023RESHAPE LIFESCIENCES INC
CUSIP 76090R200
—COM072,866+72,866$0$18,195+$18,1952024-02-14
Q4 2023SENSEI BIOTHERAPEUTICS INC
CUSIP 81728A108
—COM025,803+25,803$0$17,856+$17,8562024-02-14